Founded in 1987, Temptime scientists developed the first miniaturized technology to monitor temperature exposure of vials containing the oral polio vaccine. This time-temperature monitoring device continues to be the only technology that meets the strict specifications of the world?s leading health organization for distributing vaccines to developing countries. It satisfies the World Health Organization?s (WHO) PQS VVM performance specification, and we follow WHO?s guidelines for manufacturers of temperature monitoring devices. Today, pharmaceutical corporations, biotechnology companies and hospitals are using our devices to help improve the storage and handling of hundreds of medical products by visually identifying when a temperature excursion has occurred. We are honored to serve these organizations and contribute to improving the health of people around the world. Temptime is dedicated to continually developing new technologies that will meaningfully improve global health.
1 to 50
TypeCompany - Private
RevenueLess than $1 million (USD) per year
IndustryAdvertising & Marketing
CompetitorsUnknown
Founded1987